logo

Health Care News

Share

Aerpio Pharma Says TIME-2b Study Did Not Meet Primary Endpoint

Novo Nordisk Settles US Patent Litigation Case On Victoza With Teva

AstraZeneca: FDA Grants Saracatinib ODD For Idiopathic Pulmonary Fibrosis

EU Approves Roche's MabThera For Rare Autoimmune Disease

Spire Healthcare Appoints Martin Angle As Independent Non-Executive Director